High HDAC-4 expression was more frequently observed in pancreatic adenocarcinoma patients with absence of lymph node metastases and increased tumor proliferative capacity, at a non significant level though (Table 4, p = 0.0571 and p = 0.0576, respectively). Here, HDAC4 is linked to neoplasm.